Printer Friendly

Hitachi and Nanogen Enter Long-Term Agreement.

San Diego, CA 8/2/00-Hitach Ltd./Nissei Sangyo/Hitachi Instruments Service of Japan and Nanogen have signed a ten-year agreement to develop, manufacture and distribute products based on their joint technologies. Under the agreement, the companies will jointly invest around $57 million in applications development and approximately $140 million in development, manufacturing and distribution. In addition, Hitach will make an equity investment in Nanogen. Initially, Hitach will develop complementary instruments, possibly including a small, inexpensive instrument and a point-of-care instrument. Nanogen will expand applications for its NanoChip system and workstation.

Hitachi has been making its move into the genomics arena and has targeted microarray chips as a key technology. Its investment in Nanogen's technology gives Nanogen an edge in the crowded microarray field in that it will have expanded resources and complementary technologies and instrumentation. This agreement is an extension of the companies' partnership formed earlier this year.
COPYRIGHT 2000 Strategic Directions International Inc. (SDI)
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2000 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Comment:Hitachi and Nanogen Enter Long-Term Agreement.
Publication:Instrument Business Outlook
Geographic Code:1USA
Date:Aug 15, 2000
Words:149
Previous Article:Sybron Makes Two More Acquisitions.
Next Article:Thermo Electron Subsidiary Acquires Company.
Topics:


Related Articles
Hitachi Signs Agreement for Biochip.
NANOGEN SHIPS FIRST MOLECULAR BIOLOGY WORKSTATION TO AVENTIS.
Random Samples.
2001: The year of the microarray?
Nanogen and Bio-Rad sign licensing agreement.
The bottom line.
Market profile: biological safety cabinets.

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters